EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Volume 20 / Numéro 86 (2023) Le Nouveau Praticien Vét canine & féline, 20 86 (2023) 16-23 References
Diabète
Free Access
Issue
Le Nouveau Praticien Vét canine & féline
Volume 20, Number 86, 2023
Diabète
Page(s) 16 - 23
Section Dossier : Diabète sucré chez le chien et le chat – 2e partie
DOI https://doi.org/10.1051/npvcafe/2024016
Published online 21 juin 2024
  • Niessen SJM, Hazuchova K, Powney SL, Guitian J, Niessen APM, Pion PD, et al. The Big Pet Diabetes Survey: Perceived Frequency and Triggers for Euthanasia. Vet Sci. 2017;4(2):27. [PubMed] [Google Scholar]
  • Glior C. Chapter 33 - Gastrointestinal hormones and the use of non-insulin therapies for diabetes mellitus. In: Feline Endocrinology, Feldman E, Fracassi E and Peterson M. 2019; p. 489–502. (Edra; vol. 1). [Google Scholar]
  • European Society of Veterinary Endocrinolgy. ALIVE Project. Definition: treatment goals of diabetes mellitus 2021 [Internet]. [cité 5 nov 2023]. Disponible sur: https://www.esve.org/alive/search.aspx/ [Google Scholar]
  • Fracassi F. Chapitre 32 : Insulin treatment of diabetes mellitus. In: Feline endocrinology - Feldman E, Fracassi F, Peterson M. Edra. Milano, Italie; 2019; p. 468–81. [Google Scholar]
  • Gostelow R. Chapter 36: Diabetic remission. In: Feline endocrinology - Feldman E, Fracassi F, Peterson M. Edra. Minalo, Italy; 2019; p. 542–55. [Google Scholar]
  • Nack R, DeClue AE. In cats with newly diagnosed diabetes mellitus, use of a near-euglycemic management paradigm improves remission rate over a traditional paradigm. Vet Q. 2014;34(3):132–6. [CrossRef] [PubMed] [Google Scholar]
  • Hafner M, Dietiker-Moretti S, Kaufmann K, Mueller C, Lutz TA, Reusch CE, et al. Intensive intravenous infusion of insulin in diabetic cats. J Vet Intern Med. 2014;28(6):1753–9. [CrossRef] [Google Scholar]
  • Krämer AL, Riederer A, Fracassi F, Boretti FS, Sieber-Ruckstuhl NS, Lutz TA, et al. Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release. J Vet Intern Med. 2020;34(6):2287–95. [CrossRef] [PubMed] [Google Scholar]
  • Zini E, Salesov E, Dupont P, Moretto L, Contiero B, Lutz TA, et al. Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats. J Vet Intern Med. 2018;32(3):978–85. [CrossRef] [PubMed] [Google Scholar]
  • Reusch C., Salesov E. Chapter 35: Monitoring diabetes in cats. In: Feline endocrinology, Feldman E, Fracassi F, Peterson M. Edra. Milano, Italy; 2019; p. 522–41. [Google Scholar]
  • Sallander M, Eliasson J, Hedhammar A. Prevalence and risk factors for the development of diabetes mellitus in Swedish cats. Acta Vet Scand. 2012;54(1):61. [CrossRef] [PubMed] [Google Scholar]
  • Verkest KR, Rand JS, Fleeman LM, Morton JM. Spontaneously obese dogs exhibit greater postprandial glucose, triglyceride, and insulin concentrations than lean dogs. Domest Anim Endocrinol. 2012;42(2):103–12. [CrossRef] [PubMed] [Google Scholar]
  • Behrend E, Holford A, Lathan P, Rucinsky R, Schulman R. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. J Am Anim Hosp Assoc. 2018;54(1):1–21. [CrossRef] [PubMed] [Google Scholar]
  • Gilor C, Rudinsky AJ, Hall MJ. New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs. J Feline Med Surg. 2016;18(9):733–43. [CrossRef] [PubMed] [Google Scholar]
  • Scuderi MA, Ribeiro Petito M, Unniappan S, Waldner C, Mehain S, McMillian CJ, et al. Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus. Domest Anim Endocrinol. 2018;65:80–9. [CrossRef] [PubMed] [Google Scholar]
  • Riederer A, Zini E, Salesov E, Fracassi F, Padrutt I, Macha K, et al. Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus. J Vet Intern Med. 2016;30(1):92–100. [CrossRef] [Google Scholar]
  • Padrutt I, Lutz TA, Reusch CE, Zini E. Effects of the glucagon-like peptide-1 (GLP-1) analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats. Res Vet Sci. 2015;99:23–9. [CrossRef] [PubMed] [Google Scholar]
  • Hoenig M, Clark M, Schaeffer DJ, Reiche D. Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats. Journal of Veterinary Pharmacology and Therapeutics. 2018;41(2):266–73. [CrossRef] [PubMed] [Google Scholar]
  • Behrend EN, Ward C, Chukwu V, Cook A, Kroh C, Lathan P, Schermerhorn T, Scott-Moncrieff JC, Voth R. Velagliflozin, an SGLT2 inhibitor, as once-daily, oral solution, stand-alone therapy for feline diabetes mellitus - 2023 ACVIM Forum Research Report Program. Journal of Veterinary Internal Medicine. 2023;37(6):2638–60. [CrossRef] [Google Scholar]
  • Niessen S.J.M., Voth R, Kroh C, Hennings L. Once daily oral therapy for feline diabetes mellitus: SGLT-2-inhibitor velagliflozin as stand-alone therapy compared to insulin injection therapy in diabetic cats - Research Communications of the 32nd ECVIM-CA Online Congress. Journal of Veterinary Internal Medicine. 2022;36(6):2455–551. [CrossRef] [Google Scholar]
  • Hadd MJ, Bienhoff SE, Little SE, Geller S, Ogne-Stevenson J, Dupree TJ, et al. Safety and effectiveness of the sodium-glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus. J Vet Intern Med. 2023;37(3):915–24. [CrossRef] [Google Scholar]
  • Nelson R, Spann D, Elliott D, Brondos A, Vulliet R. Evaluation of the oral antihyperglycemic drug metformin in normal and diabetic cats. J Vet Intern Med. 2004;18(1):18–24. [CrossRef] [PubMed] [Google Scholar]
  • Mazzaferro EM, Greco DS, Turner AS, Fettman MJ. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet. J Feline Med Surg. 2003;5(3):183–9. [CrossRef] [PubMed] [Google Scholar]
  • Feldman EC, Nelson RW, Feldman MS. Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus. J Am Vet Med Assoc. 1997;210(6):772–7. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.